Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,966,000 | N/A | N/A |
| Marketable Securities | 546,000 | N/A | N/A |
| Receivables | 1,467,000 | N/A | N/A |
| Inventories | 1,044,000 | N/A | N/A |
| Other current assets | 399,000 | 0 | 0 |
| TOTAL | $5,422,000 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,188,000 | N/A | N/A |
| Other Non-Current Assets | 663,000 | 0 | 0 |
| TOTAL | $2,851,000 | $N/A | $N/A |
| Total Assets | $8,273,000 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 476,000 | 0 | 0 |
| Accrued Expenses | 974,000 | N/A | N/A |
| TOTAL | $2,613,000 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 284,000 | N/A | N/A |
| aiOther Non-Current Liabilities | 428,000 | 0 | 0 |
| TOTAL | $712,000 | $N/A | $N/A |
| Total Liabilities | $3,325,000 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 55,000 | N/A | N/A |
| Retained earnings | 5,207,000 | N/A | N/A |
| Other shareholders' equity | -114,000 | 0 | 0 |
| TOTAL | $4,948,000 | $N/A | $N/A |
| Total Liabilities And Equity | $8,273,000 | $0 | $0 |